CELLINK AB announced the acquisition of Visikol and Nanoscribe to expand its portfolio and to secure its market leadership.
CELLINK, a global leader in developing and delivering life-science solutions, has joined forces with Lonza, the Swiss Chemicals and Biotechnology Company, to offer a comprehensive 3D Bioprinting solution designed to advance complete 3D cell culture workflows.
